611 related articles for article (PubMed ID: 26305715)
1. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
2. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis.
Lu C; Xu W; Zhang F; Shao J; Zheng S
Mol Pharm; 2016 Dec; 13(12):4043-4053. PubMed ID: 27764939
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2.
Lu C; Jiang Y; Zhang F; Shao J; Wu L; Wu X; Lian N; Chen L; Jin H; Chen Q; Lu Y; Zheng S
Life Sci; 2015 Nov; 141():119-27. PubMed ID: 26341692
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Toxicol Sci; 2017 Feb; 155(2):432-443. PubMed ID: 27837167
[TBL] [Abstract][Full Text] [Related]
6. The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice.
Lívero FA; Stolf AM; Dreifuss AA; Bastos-Pereira AL; Chicorski R; de Oliveira LG; de Souza CE; Fabossi IA; Rabitto IS; Gremski LH; Henneberg R; Telles JE; Oude Elferink RP; Acco A
Chem Biol Interact; 2014 Jun; 217():19-27. PubMed ID: 24713361
[TBL] [Abstract][Full Text] [Related]
7. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
9. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
[TBL] [Abstract][Full Text] [Related]
10. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.
Yan C; Zhang Y; Zhang X; Aa J; Wang G; Xie Y
Biomed Pharmacother; 2018 Sep; 105():274-281. PubMed ID: 29860219
[TBL] [Abstract][Full Text] [Related]
11. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells.
Cheng Q; Li YW; Yang CF; Zhong YJ; He H; Zhu FC; Li L
Chem Biol Interact; 2018 Aug; 291():180-189. PubMed ID: 29940154
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide attenuates ethanol-induced hepatic steatosis by inhibiting oxidative stress and apoptosis.
Chen LY; Chen Q; Cheng YF; Jin HH; Kong DS; Zhang F; Wu L; Shao JJ; Zheng SZ
Biomed Pharmacother; 2016 Apr; 79():35-43. PubMed ID: 27044810
[TBL] [Abstract][Full Text] [Related]
13. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress.
Lu C; Xu W; Zhang F; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
Int Immunopharmacol; 2015 Dec; 29(2):613-621. PubMed ID: 26459052
[TBL] [Abstract][Full Text] [Related]
15. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
[TBL] [Abstract][Full Text] [Related]
16. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
17. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR.
Li L; Xu S; Wang W; Li X; Wang H; Yang Q; Wang C; Gu J; Luo H; Meng Q
Phytomedicine; 2024 Jul; 130():155693. PubMed ID: 38763006
[TBL] [Abstract][Full Text] [Related]
18. Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice.
Wang T; Yang P; Zhan Y; Xia L; Hua Z; Zhang J
Toxicology; 2013 Dec; 314(2-3):193-201. PubMed ID: 24144995
[TBL] [Abstract][Full Text] [Related]
19. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
20. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]